Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility
Agreement Provides Greater Financial Flexibility as Company Continues to Reduce Debt LAKE FOREST, Ill. , Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended its Senior Secured Credit Facility, replacing the previous fixed adjusted EBITDA
Toggle Summary Assertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin Depot
-- Submission Advances Company’s Strategy to Build A New Orphan/Specialty Business and Aligns with Company’s Mission of Putting Patients First -- LAKE FOREST, Ill. , Dec. 20, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has submitted to the U.S.
Toggle Summary Assertio Therapeutics Announces Third-Quarter 2018 Financial Results
-- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Raises Full-Year Earnings Guidance and Confirms Adjusted EBITDA Guidance -- -- Amends and Strengthens Commercial Agreement with Collegium -- -- Confirms Regulatory Plan to File for FDA Approval of Cosyntropin Depot by

Upcoming Events

There are currently no events to display.
Presentations

Recent SEC Filings

Filing date Description Form Filing Group View

Optional form for the registration of securities to be sold to the public by small business issuers

SB-2
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

Registration of certain classes of securities 12(b) of the Securities Exchange Act

8-A12B
Registration Statements
View HTML

Substantive changes from or additions to a prospectus previously filed

424A
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com